Sydney Archer

3.3k total citations
112 papers, 2.5k citations indexed

About

Sydney Archer is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sydney Archer has authored 112 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 34 papers in Organic Chemistry and 32 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sydney Archer's work include Neuropeptides and Animal Physiology (29 papers), Receptor Mechanisms and Signaling (19 papers) and Pharmacological Receptor Mechanisms and Effects (15 papers). Sydney Archer is often cited by papers focused on Neuropeptides and Animal Physiology (29 papers), Receptor Mechanisms and Signaling (19 papers) and Pharmacological Receptor Mechanisms and Effects (15 papers). Sydney Archer collaborates with scholars based in United States and Italy. Sydney Archer's co-authors include Donato Cioli, Livia Pica‐Mattoccia, Jean M. Bidlack, Stanley D. Glick, S.D. Glick, I.M. Maisonneuve, Isabelle M. Maisonneuve, D. A. Berberian, H. Freele and David Rosi and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Sydney Archer

111 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sydney Archer United States 27 1.1k 904 504 498 245 112 2.5k
Tag E. Mansour United States 32 1.4k 1.2× 284 0.3× 597 1.2× 147 0.3× 642 2.6× 118 3.5k
Peter T. Meinke United States 33 2.2k 2.0× 256 0.3× 152 0.3× 904 1.8× 123 0.5× 108 4.2k
Urs Duthaler Switzerland 27 256 0.2× 577 0.6× 387 0.8× 697 1.4× 308 1.3× 88 2.2k
John P. Davis United States 18 503 0.4× 243 0.3× 97 0.2× 111 0.2× 279 1.1× 47 1.7k
Craig L. Barsuhn United States 20 656 0.6× 439 0.5× 61 0.1× 48 0.1× 154 0.6× 32 1.6k
Boris S. Zhorov Canada 35 2.9k 2.5× 1.2k 1.4× 67 0.1× 218 0.4× 13 0.1× 153 4.0k
Mark S. Schmidt United States 21 666 0.6× 208 0.2× 96 0.2× 135 0.3× 31 0.1× 45 2.4k
Charles A. Nichol United States 34 2.0k 1.8× 245 0.3× 37 0.1× 587 1.2× 25 0.1× 113 4.2k
Peter R. Andrews Australia 22 1.3k 1.1× 446 0.5× 26 0.1× 573 1.2× 28 0.1× 71 2.2k
P. J. Ham United Kingdom 19 411 0.4× 364 0.4× 84 0.2× 196 0.4× 15 0.1× 64 1.2k

Countries citing papers authored by Sydney Archer

Since Specialization
Citations

This map shows the geographic impact of Sydney Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sydney Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sydney Archer more than expected).

Fields of papers citing papers by Sydney Archer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sydney Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sydney Archer. The network helps show where Sydney Archer may publish in the future.

Co-authorship network of co-authors of Sydney Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Sydney Archer. A scholar is included among the top collaborators of Sydney Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sydney Archer. Sydney Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McLaughlin, Jay P., et al.. (1997). 14β-Chlorocinnamoylamino derivatives of metopon: long-term μ-opioid receptor antagonists. European Journal of Pharmacology. 320(2-3). 121–129. 8 indexed citations
2.
Emmerson, Paul J., et al.. (1997). Synthesis and Characterization of 4,4-Difluoro-4-bora-3a,4a-Diaza-s-Indacene (BODIPY)-Labeled Fluorescent Ligands for the Mu Opioid Receptor. Biochemical Pharmacology. 54(12). 1315–1322. 32 indexed citations
3.
Archer, Sydney, Stanley D. Glick, & Jean M. Bidlack. (1996). Cyclazocine revisited. Neurochemical Research. 21(11). 1369–1373. 61 indexed citations
4.
Glick, Stanley D., et al.. (1995). Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Research. 681(1-2). 147–152. 196 indexed citations
5.
Hough, Lindsay B., et al.. (1995). Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry. Biochemical Pharmacology. 49(1). 73–79. 23 indexed citations
6.
Cioli, Donato, Livia Pica‐Mattoccia, & Sydney Archer. (1995). Antischistosomal drugs: Past, present … and future?. Pharmacology & Therapeutics. 68(1). 35–85. 198 indexed citations
7.
McLaughlin, Jay P., et al.. (1995). Metopon and two unique derivatives: affinity and selectivity for the multiple opioid receptors. European Journal of Pharmacology. 294(1). 201–206. 7 indexed citations
8.
9.
10.
11.
Jiang, Qi, et al.. (1993). 5β-Methyl-14β-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: A long-lasting μ-opioid receptor antagonist devoid of agonist properties. European Journal of Pharmacology. 230(1). 129–130. 4 indexed citations
12.
Simon, Eric, et al.. (1993). Photoaffinity ligands for the MU opioid receptor. Life Sciences. 53(14). 1173–1178. 1 indexed citations
13.
Pica‐Mattoccia, Livia, Sydney Archer, & Donato Cioli. (1992). Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules. Molecular and Biochemical Parasitology. 55(1-2). 167–175. 23 indexed citations
14.
Archer, Sydney, et al.. (1988). The preparation, antischistosomal and antitumor activity of hycanthone and some of its congeners. Evidence for the mode of action of hycanthone. Journal of Medicinal Chemistry. 31(1). 254–260. 45 indexed citations
15.
Pica‐Mattoccia, Livia, et al.. (1988). Studies on some derivatives of oxamniquine. Journal of Medicinal Chemistry. 31(8). 1629–1631. 10 indexed citations
16.
Maneckjee, Rhoda, Sydney Archer, & R. Suzanne Zukin. (1988). Characterization of a polyclonal antibody to the μ opioid receptor. Journal of Neuroimmunology. 17(3). 199–208. 7 indexed citations
17.
Pica‐Mattoccia, Livia, Donato Cioli, & Sydney Archer. (1988). Binding of tritiated hycanthone and hycanthone N-methylcarbamate to macromolecules of drug-sensitive and drug-resistant schistosomes. Molecular and Biochemical Parasitology. 31(1). 87–96. 22 indexed citations
18.
Archer, Sydney, et al.. (1986). Synthesis of 5-hydroxymethyl-11-methyl-6H-pyrido[4,3-b]carbazole and 5-formyl-11-methyl-6H-pyrido[4,3-b]carbazole (17-oxoellipticine). Tetrahedron Letters. 27(44). 5343–5346. 1 indexed citations
19.
Archer, Sydney, et al.. (1972). Recent Developments in the Chemotherapy of Schistosomiasis. Birkhäuser Basel eBooks. 16. 11–66. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tag E. Mansour Breakdown of academic impact, for papers by Peter T. Meinke Breakdown of academic impact, for papers by Urs Duthaler Breakdown of academic impact, for papers by John P. Davis Breakdown of academic impact, for papers by Craig L. Barsuhn Breakdown of academic impact, for papers by Boris S. Zhorov Breakdown of academic impact, for papers by Mark S. Schmidt Breakdown of academic impact, for papers by Charles A. Nichol Breakdown of academic impact, for papers by Peter R. Andrews Breakdown of academic impact, for papers by P. J. Ham
Rankless by CCL
2026